Waltham, Massachusetts, United States In 2006 was created Massachusetts Life Sciences Center, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Waltham. The venture was found in North America in United States.
The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Medical, Genetics. Among the various public portfolio startups of the fund, we may underline Candel, Massachusetts Biomedical Initiatives, Baystate Health For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund.
The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Massachusetts Life Sciences Center works on 17 percentage points less the average amount of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2016.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Massachusetts Life Sciences Center, startups are often financed by National Institutes of Health, MassChallenge, National Science Foundation. The meaningful sponsors for the fund in investment in the same round are MassChallenge, Center for the Advancement of Science in Space. In the next rounds fund is usually obtained by National Science Foundation, National Institutes of Health, Massachusetts Office of International Trade and Investment (MOITI).
Related Funds
Funds with similar focus
| Fund Name | Location |
| 757 Angels | Norfolk, United States, Virginia |
| Cardiovascular Systems | Minnesota, Saint Paul, United States |
| Gridsum Holding | - |
| Redhawk Ventures | Ohio, Oxford, United States |
| Sparkasse Bank Makedonija | North Macedonia, Skopje, Skopje Region |
| Taubman Centers Inc. | Bloomfield Hills, Michigan, United States |
| Tenderloin Ventures | Switzerland, Zug, Zug |
| Thawer Capital Management (UK) | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AcousticaBio | $50K | 09 Apr 2021 | Cambridge, Massachusetts, United States | ||
ImmuneXcite | $3M | 07 Jan 2014 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AcousticaBio | $50K | 09 Apr 2021 | Cambridge, Massachusetts, United States | ||
ImmuneXcite | $3M | 07 Jan 2014 | Massachusetts, United States |
